SG13 Managing cutaneous manifestations of FH-associated tumour predisposition syndrome: a systematic review of case reports

Amber O’Brien,Schaida Schirwani

DOI: https://doi.org/10.1093/bjd/ljae090.395

IF: 11.113

2024-06-28

British Journal of Dermatology

Abstract:Abstract The cutaneous manifestations of fumarate hydratase (FH)-associated tumour predisposition syndrome, otherwise called hereditary leiomyomatosis and renal cell carcinoma (HLRCC), can be managed in a variety of ways including surgical excision, oral and topical analgesia, laser therapy and cryotherapy. While some of these methods are considered well established, others are less widely used and there is little evidence reported comparing the outcomes after treatment. This systematic review of case reports aims to determine how symptom burden after surgical excision of the cutaneous lesions differs from symptom burden after analgesic treatment or other methods. The databases OVID MEDLINE, Embase and Scopus were searched with terms such as ‘HLRCC’, ‘cutaneous’, ‘leiomyoma’ and ‘management’. In total, 19 case reports with a total of 23 patients diagnosed with HLRCC and cutaneous manifestations, for example leiomyomas, were included in this systematic review. These case reports were dated between 2009 and 2022. Eleven of these patients had their cutaneous lesions treated with surgical excision, eight were treated with analgesia and nine were treated with ‘other methods’. ‘Other methods’ was defined as any treatment that was not surgical or simple analgesia, and included carbon dioxide laser therapy, erbium laser therapy, liquid nitrogen cryotherapy, phototherapy, botulinum toxin, electrocoagulation, and immunosuppression with azathioprine. Some patients were treated with a combination of methods. Surgical excision showed the poorest symptom outcomes after treatment, with 9% of patients showing improvement of symptom control after treatment compared with 75% of patients having symptom improvement with analgesic treatment and 89% after ‘other methods’. When surgical excision was combined with analgesia or ‘other methods’, symptom control was improved compared with surgical excision when used alone. This review shows that surgical excision may not provide optimal symptom control for patients with cutaneous manifestations of HLRCC, and other treatments should be considered. Surgical excision of cutaneous lesions allows histopathological confirmation of leiomyomata and therefore has an important role in the diagnosis of HLRCC, so it should not be excluded from treatment recommendations. However, clinicians should consider combining excision with another treatment, for example analgesia with agents such as gabapentin. Further research in the form of a large cohort study or randomized control trial is necessary to confirm the observations made by this systematic review by providing more quantitative data.

dermatology